Type
Business expansion
Country
Sweden
Region
Stockholm; Stockholms län;
Location of affected unit(s)
Stockholm
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.2 - Manufacture of pharmaceutical preparations

120 jobs
Number of planned job creations
Job creation
Announcement Date
26 February 2016
Employment effect (start)
Foreseen end date

Description

Swedish-Swiss pharmaceutical company Octapharma is to hire 120 new employees following renewed production permits from the country administrative board permitting larger production volumes at Octapharma's factory in Kungsholmen, Stockholm.  Octapharma produces protein based pharmaceuticals from plasma. Currently Octapharma has the capacity to produce 1,500 (metric) tonnes of protein based pharmaceuticals yearly, following the renewed permit Octapharma will have the capacity to produce 3,500 tonnes, with plans to produce 2,700 tonnes of pharmaceuticals yearly before the end of 2017. 

Beyond hiring new staff Octapharma with improve its production capacity through modernisation and reconstruction of its factory. Octapharma has an investment scheme for its factory in Stockholm amounting to a total of €39 million during 2016.


Sources

  • 26 February 2016: Kemivärlden Biotech

Citation

Eurofound (2016), Octapharma, Business expansion in Sweden, factsheet number 86636, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/86636.